N-myristoylation

Show results for

Unknown (257)
Proteomics (59)
Transcriptomics (5)
Genomics (5)

Organisms

Bombyx mori (47)
Schizosaccharomyces pombe (47)
Human immunodeficiency virus 1 (47)
Oryza sativa Indica Group (47)
Sinorhizobium meliloti BL225C (47)
Sus scrofa domesticus (47)
Ostreococcus tauri (47)
Saccharomyces cerevisiae (47)
Synechocystis sp. PCC 6803 (47)
Olavius algarvensis Gamma 1 endosymbiont (47)
Vitis vinifera (47)
Staphylococcus aureus (47)
Rattus norvegicus (47)
Rattus rattus (47)
Olavius algarvensis Delta 4 endosymbiont (47)
Escherichia coli (47)
Candida albicans (47)
Cyanophora paradoxa (47)
Equus caballus (47)
Bursaphelenchus xylophilus (47)
Pseudomonas aeruginosa SJTD-1 (47)
Rhizobium sp. Leaf68 (47)
Canis lupus familiaris (47)
Camelus dromedarius (47)
Entamoeba histolytica (47)
Physcomitrium patens (47)
Olavius algarvensis Delta 1 endosymbiont (47)
Homo sapiens (5)
Mus musculus (3)
cellular organisms (1)

Organisms

Homo sapiens (2)
Mus musculus (2)

Repository

pride (48)
MassIVE (8)
ENA (5)
geo (4)
jPOST (3)
biostudies-arrayexpress (1)

Tissue

Cell culture (14)
Permanent cell line cell (6)
Whole body (4)
Brain (3)
Liver (3)
Epithelial cell (2)
B cell (2)
Neural crest derived neuroblast (1)
Epithelial cell line (1)
Layer of hippocampus (1)
Foreskin fibroblast (1)
Cerebral cortex neuron (1)
Plant cell (1)
Cardiac muscle cell (1)
Heart (1)
Root (1)
Embryo (1)
Obsolete lymphoblast (1)
Endothelial cell of umbilical vein (1)
Rosette (1)
Fibroblast (1)
Kidney (1)
Blood cell (1)

Disease

Plasmodium falciparum malaria (2)
Chagas disease (2)
Lymphoma (2)
Neuroblastoma (2)
Neurological dysfunction (1)
Toxoplasmosis (1)
Autosomal recessive polycystic kidney disease (1)
Trypanosomiasis (1)
Breast cancer (1)

Technology Type

Mass Spectrometry (48)
Shotgun proteomics (28)
Bottom-up proteomics (12)
Affinity purification coupled with mass spectrometry proteomics (7)
Data-dependent acquisition (6)
Data-independent acquisition (3)
Gel-based experiment (3)
SWATH MS (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)

Instrument Platform

LTQ Orbitrap (5)
LTQ Orbitrap Velos (1)
Q Exactive (1)
Orbitrap Fusion Lumos (1)

Publication Date

2025 (9)
2016 (8)
2018 (8)
2023 (7)
2021 (7)
2024 (6)
2026 (4)
2022 (3)
2017 (3)
2020 (3)
2010 (2)
2015 (2)
2019 (1)
2014 (1)

First Public Date

2025 (2)
2023 (1)
2022 (1)
2014 (1)

Modification

+3amu) (1)
4-tetrahydrothiazine-3-carboxylic acid (1)

Study type

Transcription profiling by array (1)

Release Date

2023 (20)
2025 (18)
2019 (18)
2010 (17)
2017 (16)
2020 (15)
2021 (14)
2012 (14)
2024 (13)
2018 (13)
2011 (13)
2016 (12)
2015 (12)
2009 (12)
2022 (9)
2013 (8)
2008 (7)
2014 (6)
2007 (6)
2006 (4)
2026 (2)
2005 (2)
2004 (2)
2003 (2)
2002 (1)
2001 (1)
2000 (1)

Lab affiliation

Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, London, W12 0BZ, UK The Francis Crick Institute, London, NW1 1AT, UK (4)
Department of Chemistry, Imperial College London, Exhibition Road, London SW7 2AZ, UK (3)
Department of Clinical Laboratory, Shanghai Tenth People’s Hospital of Tongji University, Shanghai, 200072, China (3)
GSK Chair in Chemical Biology, Imperial College London Satellite Group Leader, Francis Crick Institute Founder & SAB, Myricx Bio https://myricxbio.com/ Room 301B, Molecular Sciences Research Hub, White City Campus 82 Wood Lane, London W12 0BZ, UK Tel.: 020759 + Ext. 43752 or 45821 (group) http://www.imperial.ac.uk/tate-group/ (2)
Department of Chemistry, Imperial College London, Molecular Research Science Hub, 82 Wood Lane, London W12 0BZ, United Kingdom. The Francis Crick Institute, 1 Midland Road, London NW1 1AT, United Kingdom. (2)
Department of Chemistry, Imperial College London (2)
Department of Biochemistry, College of Medicine, University of Saskatchewan (2)
Institute of Chemical Biology, Department of Chemistry, Imperial College London (1)
Inserm UMRS 1256 N-GERE (Nutrition-Genetics-Environmental Risks) (1)
Department of Structural Biology, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) (1)
Prof. Edward Tate Professor of Chemical Biology, Imperial College London Satellite Group Leader, Francis Crick Institute CSO Myricx Pharma Ltd Room 301B, Molecular Sciences Research Hub, White City Campus Wood Lane, London W12 0BZ, UK (1)
Biological Chemistry and Drug Discovery University of Dundee (1)
Department of Chemistry, Imperial College London, Molecular Research Science Hub, 80 Wood Lane, London W12 0BZ, United Kingdom. The Francis Crick Institute, 1 Midland Road, London NW1 1AT, United Kingdom. (1)
Queensland Brain Institute, Univerisity of Queensland (1)
Signalling in Apicomplexan Parasites Laboratory, The Francis Crick Institute, London NW1 1AT, UK (1)
GSK Chair in Chemical Biology, Imperial College London Satellite Group Leader, Francis Crick Institute Founder & SAB, Myricx Bio (https://myricxbio.com/) Room 301B, Molecular Sciences Research Hub, White City Campus 82 Wood Lane, London W12 0BZ, UK Tel.: 020759 + Ext. 43752 or 45821 (group) http://www.imperial.ac.uk/tate-group/ (1)
Biological Sciences, The University of Texas at El Paso (1)
Department of Chemistry, Imperial College London, Molecular Research Science Hub, 80 Wood Lane, London W12 0BZ, United Kingdom. The Francis Crick Institute, 1 Midland Road, London NW1 1AT, United Kingdom. (1)
Centre for Proteome Research, Biochemistry and Systems Biology Department, University of Liverpool (1)
Professor of Chemical Biology, Imperial College London Satellite Group Leader, Francis Crick Institute Founder & SAB, Myricx Pharma Ltd Room 301B, Molecular Sciences Research Hub, White City Campus 82 Wood Lane, London W12 0BZ, UK (1)
Population genetics (1)
Biotechnology Center, National Chung-Hsing University, Taichung 402, Taiwan (1)
Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, IL, 60637, USA (1)
The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University General Hospital, Department of Immunology, Tianjin Medical University, Tianjin, 300070, China (1)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, Utrecht 3584 CH The Netherlands Netherlands Proteomics Center, Padualaan 8, Utrecht 3584 CH, The Netherlands (1)
Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague, Czech Republic (1)
CNRS (1)
Institute of Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Sud, Bâtiment 23A, 1 avenue de la Terrasse, F-91198 Gif-sur-Yvette cedex, France. (1)
Institute of Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Sud, Avenue de la Terrasse, F-91198 Gif-sur-Yvette cedex, France ( lab head ) (1)
The Francis Crick Institute 1 Midland Road London NW1 1AT (1)

Previous page
1 / 33
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 33
Next page

Sort by:

Relevance

Page size

Application of liquid-liquid extraction for N-terminal myristoylation proteomics

Proteins can be modified by lipids in various ways, for example by myristoylation, palmitoylation, farnesylation, and geranylgeranylation—these processes are collectively referred to as lipidation. Current chemical proteomics using alkyne lipids has enabled the identification of lipidated protein ca...

ORGANISM(S): Homo Sapiens (human) Mus Musculus (mouse)

2023-11-09 | PXD041499 | JPOST Repository

Inhibition of protein N-myristoylation blocks Plasmodium falciparum intracellular development and egress, but myristoylation of GAP45 is required only for erythrocyte invasion.

Inhibition of protein N-myristoylation blocks Plasmodium falciparum intracellular development and egress, but myristoylation of GAP45 is required only for erythrocyte invasion. TMT quantification used to determine protein expression changes upon inhibition of myristoylation

ORGANISM(S): Plasmodium falciparum (isolate 3D7)

2021-10-07 | PXD021879 | Pride